Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

EMD Serono launches TocopheRx, a new spin-off focused on infertility treatment

Dec. 3, 2013

Trial of gene therapy for Sanfilippo B syndrome begins

Dec. 3, 2013

Characterization and development of a potent inhibitor of cholesterol biosynthesis

Dec. 3, 2013

Daiichi Sankyo launches new formulation of natural tetrahydrobiopterin agent

Dec. 2, 2013

Japanese researchers invent novel MCH-R1 antagonists for obesity

Dec. 2, 2013

Novel MetAP 2 inhibitors patented by Zalgen for obesity

Dec. 2, 2013

DBPR-211 as a potent and orally active CB1 antagonist in vivo

Dec. 2, 2013

Orexigen plans resubmission of Contrave NDA based on interim analysis of Light Study

Nov. 29, 2013

New SGLT1 inhibitors for diabetes patented by Eli Lilly

Nov. 28, 2013

Treatment begins in Bone Therapeutics' phase IIb/III study of PREOB in non-union fractures

Nov. 28, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...